Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Retinal Degeneration Fund

Investor type Corporate Venture Capital


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 6
Average round size
The average size of a deal this fund participated in
Portfolio companies 6
Rounds per year 1.50
Lead investments 1
Exits 1
Key employees Soon

Areas of investment

  • Biotechnology
  • Health Care
  • Therapeutics
  • Life Science
  • Pharmaceutical

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Retinal Degeneration Fund:
Typical Co-investors
Retinal Degeneration Fund is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Retinal Degeneration Fund:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Carlyle Global Partners District of Columbia, United States, Washington
Chilton Investment Connecticut, Stamford, United States
Claytonia Capital California, San Francisco, United States
Indiana University Health Indiana, Indianapolis, United States
Liangshi Investment China, Gansu, Sichuan
Paladin Capital Group District of Columbia, United States, Washington
Ringier Switzerland, Zürich, Zurich
Starta Accelerator New York, New York, United States
Yatra Angel Network India, Maharashtra, Mumbai
Zhonglu Investment Management China, Shanghai

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation


Life Science
$88M14 Sep 2022 Paris, Ile-de-France, France

Nacuity Pharmaceuticals

Health Care
$16M15 Jun 2022 Fort Worth, Texas, United States

SalioGen Therapeutics

Life Science
$115M05 Jan 2022 Burlington, Massachusetts, United States

Opus Genetics

Health Care
Health Diagnostics
$19M22 Sep 2021 Raleigh, North Carolina, United States

Vedere Bio

Health Care
$77M18 May 2021 Cambridge, Massachusetts, United States

Atsena Therapeutics

Health Care
$55M16 Dec 2020 Durham, North Carolina, United States


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Retinal Degeneration Fund?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: